Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 33.58%-14.12M | -4.63%-1.88M | 28.03%-5.46M | 14.58%-4.02M | 61.44%-2.77M | -38.18%-21.26M | 29.37%-1.79M | 3.24%-7.59M | -542.11%-4.7M | -18.21%-7.18M |
| Net income from continuing operations | 0.35%-29.74M | -239.16%-11.42M | -0.54%-5.82M | 43.13%-6.29M | 35.52%-6.21M | -25.42%-29.85M | 60.77%-3.37M | 61.79%-5.79M | -488.65%-11.06M | -230.84%-9.63M |
| Operating gains losses | 158.96%2.14M | 205.83%2.94M | -264.46%-995K | ---- | ---- | 62.01%-3.63M | -330.54%-2.78M | 158.06%605K | ---- | ---- |
| Depreciation and amortization | -36.64%6.32M | -32.38%1.67M | -33.06%1.69M | -79.43%512K | -1.76%2.45M | -34.18%9.98M | -32.24%2.47M | -32.54%2.52M | -37.42%2.49M | -34.26%2.49M |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -95.06%205K | 220.00%288K | -157.25%-79K | ---- | ---- | 82.27%4.15M | -75.14%90K | -91.36%138K | ---- | ---- |
| Unrealized gains and losses of investment securities | 1,281.95%7.27M | 4,957.47%4.4M | 184.39%1.2M | 235.35%1.54M | -93.23%126K | 93.41%-615K | 102.32%87K | -135.34%-1.42M | 73.25%-1.14M | 134.76%1.86M |
| Remuneration paid in stock | -56.32%664K | -32.14%152K | -33.18%145K | -24.05%180K | -77.79%187K | -27.62%1.52M | -50.66%224K | -66.46%217K | -62.02%237K | 124.53%842K |
| Other non cashItems | -63.26%2.3M | -182.88%-1.27M | -75.42%396K | -34.69%1.7M | 192.23%1.47M | -31.27%6.25M | -50.03%1.53M | -24.68%1.61M | 34.94%2.6M | -74.36%502K |
| Change In working capital | 63.86%-3.28M | 2,772.55%1.36M | 63.48%-2M | -510.86%-1.86M | 75.79%-785K | -385.44%-9.07M | -109.86%-51K | -43.94%-5.47M | -105.68%-304K | 17.61%-3.24M |
| -Change in receivables | 1.94%368K | -66.48%177K | 7,415.38%951K | -45.24%-366K | -502.04%-394K | -89.54%361K | 54.39%528K | 72.34%-13K | -105.77%-252K | 108.09%98K |
| -Change in inventory | 107.11%108K | 144.23%889K | 45.29%-470K | -33,100.00%-330K | 101.85%19K | -134.73%-1.52M | -53.51%364K | -220.14%-859K | -99.94%1K | -186.44%-1.03M |
| -Change in prepaid assets | -82.58%232K | 2,200.00%621K | 3.75%-411K | -100.38%-6K | -81.33%28K | 1,467.06%1.33M | -95.99%27K | 68.44%-427K | 457.04%1.58M | -68.75%150K |
| -Change in payables and accrued expense | 34.56%-1.09M | 131.66%126K | -3.37%-1.01M | 71.23%-273K | -89.29%71K | -1,201.99%-1.66M | -183.09%-398K | -91.78%-980K | -174.08%-949K | 160.38%663K |
| -Change in other current liabilities | 71.02%-2.1M | 36.08%-349K | 90.48%-531K | -131.87%-615K | 80.17%-605K | 29.67%-7.25M | 78.85%-546K | -144.09%-5.58M | 176.86%1.93M | -4.31%-3.05M |
| -Change in other working capital | -141.21%-796K | -288.46%-101K | -121.94%-524K | 89.79%-267K | 226.32%96K | -188.71%-330K | -103.17%-26K | 848.59%2.39M | -1,203.80%-2.62M | 79.29%-76K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 33.58%-14.12M | -4.63%-1.88M | 28.03%-5.46M | 14.58%-4.02M | 61.44%-2.77M | -38.18%-21.26M | 29.37%-1.79M | 3.24%-7.59M | -542.11%-4.7M | -18.21%-7.18M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 89.15%-412K | 158.59%116K | 103.55%11K | 96.33%-46K | 75.75%-493K | -8.27%-3.8M | 67.54%-198K | 88.71%-310K | -1,030.63%-1.26M | -4,982.50%-2.03M |
| Capital expenditure reported | ---- | ---- | ---- | ---- | 74.71%-521K | ---- | ---- | ---- | ---- | ---2.06M |
| Net PPE purchase and sale | 85.74%-549K | 145.91%101K | 100.63%2K | ---- | ---- | -4.33%-3.85M | 67.46%-220K | 88.86%-315K | -973.50%-1.26M | -2,842.86%-2.06M |
| Net other investing changes | 149.09%137K | -31.82%15K | 80.00%9K | 8,400.00%85K | 3.70%28K | -70.27%55K | -66.67%22K | -93.98%5K | -83.33%1K | -10.00%27K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 89.15%-412K | 158.59%116K | 103.55%11K | 96.33%-46K | 75.75%-493K | -8.27%-3.8M | 67.54%-198K | 88.71%-310K | -1,030.63%-1.26M | -4,982.50%-2.03M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 65.52%-50K | -33.33%-16K | 40.00%-9K | -25.00%-25K | 0 | 42.23%-145K | 75.51%-12K | 88.19%-15K | -233.33%-20K | -42.03%-98K |
| Net other financing activities | 65.52%-50K | -33.33%-16K | 40.00%-9K | ---- | ---- | 42.23%-145K | 75.51%-12K | 88.19%-15K | -233.33%-20K | -42.03%-98K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 65.52%-50K | -33.33%-16K | 40.00%-9K | -25.00%-25K | --0 | 42.23%-145K | 75.51%-12K | 88.19%-15K | -233.33%-20K | -42.03%-98K |
| Net cash flow | ||||||||||
| Beginning cash position | -52.70%22.62M | -60.15%9.81M | -53.07%15.27M | -49.74%19.36M | -52.70%22.62M | -28.59%47.82M | -51.74%24.62M | -47.30%32.53M | -36.64%38.51M | -28.59%47.82M |
| Current changes in cash | 42.14%-14.58M | 11.34%-1.78M | 31.01%-5.46M | 31.61%-4.09M | 64.97%-3.26M | -31.65%-25.2M | 37.36%-2M | 26.15%-7.91M | -731.36%-5.98M | -50.60%-9.31M |
| End cash Position | -64.48%8.04M | -64.48%8.04M | -60.15%9.81M | -53.07%15.27M | -49.74%19.36M | -52.70%22.62M | -52.70%22.62M | -51.74%24.62M | -47.30%32.53M | -36.64%38.51M |
| Free cash from | 41.58%-14.67M | 11.83%-1.77M | 30.92%-5.46M | 30.39%-4.15M | 64.40%-3.29M | -31.63%-25.11M | 37.38%-2.01M | 25.94%-7.9M | -729.36%-5.96M | -50.40%-9.24M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.